BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 29471193)

  • 1. The value of tests evaluating visual functions in detecting overt or subclinical optic neuritis in multiple sclerosis.
    Öcek Ö; Gedizlioğlu M; Köşkderelioğlu A; Ortan PK; Yüksel B; Türe M; Gediz F
    Mult Scler Relat Disord; 2018 Apr; 21():63-68. PubMed ID: 29471193
    [No Abstract]   [Full Text] [Related]  

  • 2. Scanning laser polarimetry quantification of retinal nerve fiber layer thinning following optic neuritis.
    Trip SA; Schlottmann PG; Jones SJ; Kallis C; Altmann DR; Garway-Heath DF; Thompson AJ; Plant GT; Miller DH
    J Neuroophthalmol; 2010 Sep; 30(3):235-42. PubMed ID: 20531017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative visual tests after poorly recovered optic neuritis due to multiple sclerosis.
    Longbrake EE; Lancia S; Tutlam N; Trinkaus K; Naismith RT
    Mult Scler Relat Disord; 2016 Nov; 10():198-203. PubMed ID: 27919490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optical coherence tomography and visual evoked potentials: which is more sensitive in multiple sclerosis?
    Di Maggio G; Santangelo R; Guerrieri S; Bianco M; Ferrari L; Medaglini S; Rodegher M; Colombo B; Moiola L; Chieffo R; Del Carro U; Martinelli V; Comi G; Leocani L
    Mult Scler; 2014 Sep; 20(10):1342-7. PubMed ID: 24591532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple sclerosis: can retinal imaging accurately detect optic neuritis?
    Frohman EM; Balcer LJ; Calabresi PA
    Nat Rev Neurol; 2010 Mar; 6(3):125-6. PubMed ID: 20212426
    [No Abstract]   [Full Text] [Related]  

  • 6. Analysis of multiple sclerosis patients with electrophysiological and structural tests.
    Hamurcu M; Orhan G; Sarıcaoğlu MS; Mungan S; Duru Z
    Int Ophthalmol; 2017 Jun; 37(3):649-653. PubMed ID: 27538913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optic neuritis and the evaluation of visual impairment in multiple sclerosis.
    Bermel RA; Balcer LJ
    Continuum (Minneap Minn); 2013 Aug; 19(4 Multiple Sclerosis):1074-86. PubMed ID: 23917102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early diagnosis, monitoring, and treatment of optic neuritis.
    Chan JW
    Neurologist; 2012 Jan; 18(1):23-31. PubMed ID: 22217611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pattern VECPs in optic neuritis caused by multiple sclerosis].
    Kakisu Y; Adachi-Usami E; Mizota A
    Nippon Ganka Gakkai Zasshi; 1987 Feb; 91(2):230-4. PubMed ID: 3604813
    [No Abstract]   [Full Text] [Related]  

  • 10. Color vision versus pattern visual evoked potentials in the assessment of subclinical optic pathway involvement in multiple sclerosis.
    Gundogan FC; Tas A; Altun S; Oz O; Erdem U; Sobaci G
    Indian J Ophthalmol; 2013 Mar; 61(3):100-3. PubMed ID: 23514643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereoacuity testing discloses abnormalities in multiple sclerosis without optic neuritis.
    Sobaci G; Demirkaya S; Gundogan FC; Mutlu FM
    J Neuroophthalmol; 2009 Sep; 29(3):197-202. PubMed ID: 19726941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of retinal nerve fibre layer thickness and visual evoked potentials in optic neuritis associated with multiple sclerosis.
    Chatziralli IP; Moschos MM; Brouzas D; Kopsidas K; Ladas ID
    Clin Exp Optom; 2012 Mar; 95(2):223-8. PubMed ID: 22329676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple sclerosis seen through new eyes.
    Maddess T; Lueck CJ
    Clin Exp Ophthalmol; 2017 Jan; 45(1):9-11. PubMed ID: 28147444
    [No Abstract]   [Full Text] [Related]  

  • 14. The SKILL Card test in optic neuritis: experience of the Optic Neuritis Treatment Trial. Smith-Kettlewell Institute Low Luminance. Optic Neuritis Study Group.
    Long DT; Beck RW; Moke PS; Blair RC; Kip KE; Gal RL; Katz BJ
    J Neuroophthalmol; 2001 Jun; 21(2):124-31. PubMed ID: 11450903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the Innermost Retinal Layers and Visual Evoked Potentials in Patients with Multiple Sclerosis.
    Esen E; Sizmaz S; Balal M; Yar K; Demirkiran M; Unal I; Demircan N
    Curr Eye Res; 2016 Oct; 41(10):1353-1358. PubMed ID: 26882356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of the central visual field measured by automated perimeter octopus and pattern VECP in optic neuritis].
    Fujimoto N; Adachi-Usami E
    Nippon Ganka Gakkai Zasshi; 1987 Oct; 91(10):951-5. PubMed ID: 3442278
    [No Abstract]   [Full Text] [Related]  

  • 17. Neither retinal nor brain atrophy can be shown in patients with isolated unilateral optic neuritis at the time of presentation.
    Kallenbach K; Sander B; Tsakiri A; Wanscher B; Fuglø D; Larsen M; Larsson H; Frederiksen JL
    Mult Scler; 2011 Jan; 17(1):89-95. PubMed ID: 20847000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VISTECH contrast sensitivity and pattern-VEP in multiple sclerosis patients.
    Augustinus B; Van den Bergh L; Zeyen T
    Bull Soc Belge Ophtalmol; 1990; 236():89-96. PubMed ID: 2093410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optic neuritis--a sign of multiple sclerosis or other diseases of the central nervous system.
    Nikoskelainen E; Riekkinen P
    Acta Neurol Scand; 1974; 50(6):690-718. PubMed ID: 4440449
    [No Abstract]   [Full Text] [Related]  

  • 20. [Retinal atrophy using optical coherence tomography (OCT) in 15 patients with multiple sclerosis and comparison with healthy subjects].
    Jeanjean L; Castelnovo G; Carlander B; Villain M; Mura F; Dupeyron G; Labauge P
    Rev Neurol (Paris); 2008 Nov; 164(11):927-34. PubMed ID: 18808761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.